BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 25454992)

  • 1. Screening, prevention, and treatment of congenital cytomegalovirus.
    Johnson J; Anderson B
    Obstet Gynecol Clin North Am; 2014 Dec; 41(4):593-9. PubMed ID: 25454992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization during pregnancy for congenital cytomegalovirus infection.
    Nigro G; Adler SP; La Torre R; Best AM;
    N Engl J Med; 2005 Sep; 353(13):1350-62. PubMed ID: 16192480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
    Yinon Y; Farine D; Yudin MH
    Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and antenatal management of congenital cytomegalovirus infection.
    ; Hughes BL; Gyamfi-Bannerman C
    Am J Obstet Gynecol; 2016 Jun; 214(6):B5-B11. PubMed ID: 26902990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus: should we screen pregnant women for primary infection?
    Johnson JM; Anderson BL
    Am J Perinatol; 2013 Feb; 30(2):121-4. PubMed ID: 23292913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD; Neuberger P; Vochem M; Lihs A; Karck U; Enders M
    Arch Gynecol Obstet; 2018 Jun; 297(6):1389-1395. PubMed ID: 29404743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
    Revello MG; Lazzarotto T; Guerra B; Spinillo A; Ferrazzi E; Kustermann A; Guaschino S; Vergani P; Todros T; Frusca T; Arossa A; Furione M; Rognoni V; Rizzo N; Gabrielli L; Klersy C; Gerna G;
    N Engl J Med; 2014 Apr; 370(14):1316-26. PubMed ID: 24693891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Findings and conclusions from CMV hyperimmune globulin treatment trials.
    Adler SP; Nigro G
    J Clin Virol; 2009 Dec; 46 Suppl 4():S54-7. PubMed ID: 19781985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.
    Naing ZW; Scott GM; Shand A; Hamilton ST; van Zuylen WJ; Basha J; Hall B; Craig ME; Rawlinson WD
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):9-18. PubMed ID: 26391432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in the diagnosis of congenital cytomegalovirus infection.
    Lazzarotto T; Guerra B; Lanari M; Gabrielli L; Landini MP
    J Clin Virol; 2008 Mar; 41(3):192-7. PubMed ID: 18054840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
    J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital cytomegalovirus infection--clinical characteristics including prenatal diagnosis].
    Milewska-Bobula B
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):123-7. PubMed ID: 15537252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19)].
    Szenborn L
    Przegl Lek; 2010; 67(1):54-7. PubMed ID: 20509575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of maternal-fetal transmission of cytomegalovirus.
    Adler SP; Nigro G
    Clin Infect Dis; 2013 Dec; 57 Suppl 4():S189-92. PubMed ID: 24257425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
    Albright CM; Werner EF; Hughes BL
    Am J Perinatol; 2019 Jun; 36(7):678-687. PubMed ID: 30567003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital cytomegaly--advances in diagnosis and therapy].
    Milewska-Bobula B; Lipka B
    Przegl Epidemiol; 2009; 63(1):79-83. PubMed ID: 19522232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
    Hamilton ST; van Zuylen W; Shand A; Scott GM; Naing Z; Hall B; Craig ME; Rawlinson WD
    Rev Med Virol; 2014 Nov; 24(6):420-33. PubMed ID: 25316174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.